Literature DB >> 23365437

The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner.

Emma Poole1, Anett Walther, Kathy Raven, Christopher A Benedict, Gavin M Mason, John Sinclair.   

Abstract

It is generally accepted that, following primary infection, human cytomegalovirus (HCMV) establishes lifelong latency in CD34(+) progenitor cells and other derivative cells of the myeloid lineage. In this study, we show that the viral UL144 gene is expressed during latent infection in two cell types of the myeloid lineage, CD34(+) and CD14(+) monocytes, and that the UL144 protein is functional in latently infected monocytes. However, this latency-associated expression of UL144 occurs only in certain isolates of HCMV and depends on the presence of functional GATA-2 transcription factor binding sites in the UL144 promoter, in contrast to the viral latency-associated gene LUNA, which we also show is regulated by GATA-2 but expressed uniformly during latent infection independent of the virus isolate. Taken together, these data suggest that the HCMV latency-associated transcriptome may be virus isolate specific and dependent on the repertoire of transcription factor binding sites in the promoters of latency-associated genes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365437      PMCID: PMC3624344          DOI: 10.1128/JVI.03497-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.

Authors:  Christine S Falk; Michael Mach; Dolores J Schendel; Elisabeth H Weiss; Ivan Hilgert; Gabriele Hahn
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 2.  Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency.

Authors:  Mariana G Bego; Stephen St Jeor
Journal:  Exp Hematol       Date:  2006-05       Impact factor: 3.084

3.  Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Authors:  N S Lurain; K S Kapell; D D Huang; J A Short; J Paintsil; E Winkfield; C A Benedict; C F Ware; J W Bremer
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

5.  Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.

Authors:  Gautier Goormachtigh; Tan-Sothéa Ouk; Alexandra Mougel; Denis Tranchand-Bunel; Eric Masy; Christophe Le Clorennec; Jean Feuillard; Georg W Bornkamm; Claude Auriault; Evelyne Manet; Véronique Fafeur; Eric Adriaenssens; Jean Coll
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection.

Authors:  Ravit Arav-Boger; Catherine A Battaglia; Tiziana Lazzarotto; Liliana Gabrielli; Jian C Zong; Gary S Hayward; Marie Diener-West; Maria P Landini
Journal:  J Infect Dis       Date:  2006-07-07       Impact factor: 5.226

7.  Impaired killing of HCMV-infected retinal pigment epithelial cells by anti-pp65 CD8(+) cytotoxic T cells.

Authors:  Sophie Allart; Jacqueline Lulé; Brigitte Serres; Thomas Jones; Jean-Luc Davignon; François Malecaze; Christian Davrinche
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-02       Impact factor: 4.799

8.  Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease.

Authors:  Ravit Arav-Boger; Rodney E Willoughby; Robert F Pass; Jian-Chao Zong; Won-Jong Jang; Donald Alcendor; Gary S Hayward
Journal:  J Infect Dis       Date:  2002-09-30       Impact factor: 5.226

Review 9.  Latency and reactivation of human cytomegalovirus.

Authors:  John Sinclair; Patrick Sissons
Journal:  J Gen Virol       Date:  2006-07       Impact factor: 3.891

10.  The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism.

Authors:  Emma Poole; Christine A King; John H Sinclair; Antonio Alcami
Journal:  EMBO J       Date:  2006-08-24       Impact factor: 11.598

View more
  41 in total

1.  Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Authors:  Jeffrey I Cohen; Lesia Dropulic; Amy P Hsu; Christa S Zerbe; Tammy Krogmann; Kennichi Dowdell; Ronald L Hornung; Jana Lovell; Nancy Hardy; Dennis Hickstein; Edward W Cowen; Katherine R Calvo; Stefania Pittaluga; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-05-11       Impact factor: 9.079

2.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Structure of human cytomegalovirus UL144, an HVEM orthologue, bound to the B and T cell lymphocyte attenuator.

Authors:  Aruna Bitra; Ivana Nemčovičová; Gaelle Picarda; Tzanko Doukov; Jing Wang; Chris A Benedict; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

4.  Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Authors:  Monica S Humby; Christine M O'Connor
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 5.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

6.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

7.  A CMV vaccine: TREATing despite the TRICKs.

Authors:  Chris A Benedict
Journal:  Expert Rev Vaccines       Date:  2013-10-04       Impact factor: 5.217

8.  CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Authors:  John R Šedý; Ryan L Bjordahl; Vasileios Bekiaris; Matthew G Macauley; Brian C Ware; Paula S Norris; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  J Immunol       Date:  2013-06-12       Impact factor: 5.422

9.  Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.

Authors:  Basel T Assaf; Keith G Mansfield; Lisa Strelow; Susan V Westmoreland; Peter A Barry; Amitinder Kaur
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

10.  Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice.

Authors:  Lisa P Daley-Bauer; Linda J Roback; Grace M Wynn; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.